Biolevox(TM) HA one

Products

Information

Biolevox(TM) HA ONE is a hyaluronic acid (HA) gel, especially designed for a single intra-articular injection in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint. HA-based gel product contains 120 mg of sodium hyaluronate in 4.8 mm pre-filled syringe. A unique combination of optimally high molecular weight and high concentration of hyaluronate in Biolevox(TM) HA ONE creates a gel characterized with optimally high viscosity and elasticity1. Thus, Biolevox(TM) HA ONE stands as an ideal solution for a single shot viscosupplementation therapy as it provides a very high dose of optimally high molecular hyaluronate in single injection.

Product Categories

Finished Dosage Forms
- Injectables
Packaging Materials and Equipment
- Medical Devices and Medical Packaging

Distribution Areas

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)

Supplied From

Poland

Biovico Sp. z o.o.Biovico is a biotechnology and pharmaceutical company focused on researching and developing new innovative and rigorously tested products, manufacturing in the highest GMP level quality and providing with comprehensive and holistic solutions to professionals and patients around the world. From inception in 2008 R&D was a clear focus, understanding that the most important and lasting effects can come only through scientific endeavour. Very soon the first HA product Biolevox family was developed and the line continued to grow and expand.

Biolevox(TM) HA one

Information

Log in